LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Astellas Gene Therapies and Millions of Other Companies

Sign up for full access to Astellas Gene Therapies information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Strategic Partnerships Astellas Gene Therapies has been actively forming partnerships with companies like Axtria Inc., opening up opportunities to leverage synergies and promote products together.

Innovative Research With a focus on developing novel gene therapy modalities and pluripotent stem cell-derived therapies, Astellas is positioned to attract partners interested in cutting-edge research and treatments.

Mergers & Acquisitions Recent acquisitions like the purchase of Iveric Bio Inc. for $5.9 billion showcase Astellas' commitment to growth, signaling potential avenues for collaboration or product integration for businesses in the biotech sector.

Geographical Expansion While closing offices in the UK and California, Astellas continues to invest in its West Coast innovation center, hinting at potential opportunities for companies looking to align with their strategic geographic footprint.

Financial Capacity Having a revenue range of $50-100 million indicates financial stability and growth potential, making Astellas an attractive partner for businesses seeking collaborations with a financially secure biotech company.

Similar companies to Astellas Gene Therapies

✕

Access Insights for Astellas Gene Therapies and Millions of Other Companies

Sign up for full access to Astellas Gene Therapies information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Astellas Gene Therapies Tech Stack

Astellas Gene Therapies uses 8 technology products and services including Google PageSpeed, Cloudflare CDN, Percona, and more. Explore Astellas Gene Therapies's tech stack below.

  • Google PageSpeed
    Caching
  • Cloudflare CDN
    Content Delivery Network
  • Percona
    Database
  • Oracle ERP
    Enterprise
  • Font Awesome
    Font Scripts
  • Backbone.js
    Javascript Frameworks
  • Open Graph
    Miscellaneous
  • Informa
    Miscellaneous

Media & News

Astellas Gene Therapies's Email Address Formats

Astellas Gene Therapies uses at least 2 format(s):
Astellas Gene Therapies Email FormatsExamplePercentage
FLast@audentestx.comJDoe@audentestx.com
83%
FiLast@audentestx.comJoDoe@audentestx.com
3%
First.Last@audentestx.comJohn.Doe@audentestx.com
1%
FirLast@audentestx.comJohDoe@audentestx.com
2%
Last.First@audentestx.comDoe.John@audentestx.com
1%
First_Last@audentestx.comJohn_Doe@audentestx.com
1%
LastF@audentestx.comDoeJ@audentestx.com
1%
First-Last@audentestx.comJohn-Doe@audentestx.com
1%
FirstLast@audentestx.comJohnDoe@audentestx.com
1%
LFirst@audentestx.comDJohn@audentestx.com
1%
LastFirst@audentestx.comDoeJohn@audentestx.com
1%
F.Last@audentestx.comJ.Doe@audentestx.com
1%
FMiddleLast@audentestx.comJMichaelDoe@audentestx.com
1%
First@audentestx.comJohn@audentestx.com
1%
First_L@audentestx.comJohn_D@audentestx.com
1%

Frequently Asked Questions

Where is Astellas Gene Therapies's headquarters located?

Minus sign iconPlus sign iconAstellas Gene Therapies's main headquarters is located at 600 California St San Francisco, CA 94108 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Astellas Gene Therapies's phone number?

Minus sign iconPlus sign icon You can contact Astellas Gene Therapies's main corporate office by phone at
✕

Access Insights for Astellas Gene Therapies and Millions of Other Companies

Sign up for full access to Astellas Gene Therapies information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-415-818-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Astellas Gene Therapies's official website and social media links?

Minus sign iconPlus sign iconAstellas Gene Therapies's official website is astellasgenetherapies.com and has social profiles on LinkedIn.

How much revenue does Astellas Gene Therapies generate?

Minus sign iconPlus sign icon As of August 2024, Astellas Gene Therapies's annual revenue reached $75M.

What is Astellas Gene Therapies's SIC code NAICS code?

Minus sign iconPlus sign iconAstellas Gene Therapies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Astellas Gene Therapies have currently?

Minus sign iconPlus sign iconAs of August 2024, Astellas Gene Therapies has approximately 402 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Vice President Global Medical Affairs: C. P.Vice President Scientific Strategy And Corporate Development: D. B.Vice President Clinical And Medical Affairs; Head Of Medical Office: E. J.. Explore Astellas Gene Therapies's employee directory with LeadIQ.

What industry does Astellas Gene Therapies belong to?

Minus sign iconPlus sign iconAstellas Gene Therapies operates in the Biotechnology Research industry.

What technology does Astellas Gene Therapies use?

Minus sign iconPlus sign iconAstellas Gene Therapies's tech stack includes Google PageSpeedCloudflare CDNPerconaOracle ERPFont AwesomeBackbone.jsOpen GraphInforma.

What is Astellas Gene Therapies's email format?

Minus sign iconPlus sign iconAstellas Gene Therapies's email format typically follows the pattern of . Find more Astellas Gene Therapies email formats with LeadIQ.
Astellas Gene Therapies

Astellas Gene Therapies

Biotechnology ResearchCalifornia, United States201-500 Employees

Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina.

Content is intended for a US audience.

✕

Access Insights for Astellas Gene Therapies and Millions of Other Companies

Sign up for full access to Astellas Gene Therapies information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
600 California St San Francisco, CA 94108 US
Phone number
✕

Access Insights for Astellas Gene Therapies and Millions of Other Companies

Sign up for full access to Astellas Gene Therapies information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-415-818-****
Website
astellasgenetherapies.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $50M$100M

    Astellas Gene Therapies's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Astellas Gene Therapies's revenue is in the range of $50M$100M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Astellas Gene Therapies and Millions of Other Companies

Sign up for full access to Astellas Gene Therapies information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.